L'iniziativa PAT (Process Analytical Technology) di FDA ha consentito a GEA di combinare le proprie competenze di progettazione di apparecchiature e il proprio know-how per integrare degli analizzatori e dei dispositivi di misurazione online nei propri sistemi di processo in modo da consentire una reale comprensione del funzionamento del processo e aiutare i clienti a raggiungere l'obiettivo chiave di qualità del prodotto.
Visualizzazione di 4 su 10
This standalone module allows you to start developing your PAT models for a pharmaceutical continuous manufacturing process offline during the early stages of R&D.
Based on the traditional concept of a live coal-mine canary, the 21st century equivalent from GEA is a continuous real-time monitoring system that’s been designed to detect breaches in contained pharmaceutical production lines. By providing an additional level of monitoring, the Digital Canary reduces the need for routine occupational health chec...
The Lighthouse Probe® can be used for real-time monitoring of chemical and pharmaceutical processes and provides in-process window cleaning at any time, recalibration during the process, full CIP (cleaning) of wash housing and seal, and a clear view inside – even in difficult conditions.
LYOSENSE® from GEA, based on multipoint NIR measurements, provides the comprehensive and non-destructive evaluation of freeze-dried product cakes in real-time.
To support community engagement, GEA offers employees one day of paid time off per year.
How do you lead a dairy farm into the next generation while ensuring a sustainable future and animal welfare while managing increasing complexity? This is a question almost every dairy farmer around the world must consider. The...
After reaching its Mission 26 targets two years early, GEA launches Mission 2030 strategy with focus on growth, value and making a positive impact.